CS1-CAR is a new and radically different approach in cancer treatment that harnesses the power of the patients immune system to rid itself of cancer. Initial clinical trials of a similar therapy used in treating Acute Lymphocytic Leukemia showed extraordinary success 88% of patients achieved complete remission. CureTalk panelists are talking to Dr. Craig Hofmeister to help us understand this new therapy and how myeloma patients will benefit.
MMORE: Multiple Myeloma Opportunities for Research & Education (www.mmore.org) is a non-profit organization that raises funds and awareness for early-stage innovative myeloma research. MMORE spoke about this innovative research on CureTalks in March and we continue the conversation with the researchers in this episode.
Dr. Craig Hofmeister is assistant professor of medicine at the Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. Dr. Hofmeister received his medical degree from The Ohio State University and completed his internship, residency, and fellowship training at Loyola University Medical Center and Loyola Cardinal Bernardin Cancer Center in Illinois. He is board certified in Internal Medicine, Hematology and Medical Oncology. Dr. Hofmeister's clinical and research interests include multiple myeloma and blood and marrow transplantation.
On the panel are Gary Petersen, Pat Killingsworth and Jack Aiello. RSVP Now!
Sorry we couldn't complete your registration. Please try again.
You must accept the Terms and conditions to register